Award for Abinopharm Inc. NMN Human Clinical Trial

We are very happy to announce our CEO, Lin Yi, received 2024 outstanding original research paper award third prize from the American Aging Association (AGE) during AGE’s 52nd annual meeting on June 3rd, 2024 for the research paper published on GeroScience on our NMN human clinical trial.